Market-Moving News for June 12th
$BMR
$ORCL
$RNA
Computer Software: Prepackaged Software
Technology
Computer Software: Prepackaged Software
Technology
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/9/2026 | Buy → Hold | Melius | ||
| 2/9/2026 | $180.00 | Neutral → Buy | DA Davidson | |
| 2/4/2026 | $270.00 → $205.00 | Outperform | BMO Capital Markets | |
| 1/12/2026 | $240.00 | Buy | Goldman | |
| 12/11/2025 | $355.00 → $270.00 | Outperform | BMO Capital Markets | |
| 12/3/2025 | $280.00 | Overweight | Wells Fargo | |
| 11/10/2025 | Buy → Hold | Erste Group | ||
| 10/13/2025 | $345.00 → $355.00 | Outperform | BMO Capital Markets |
New AI agents embedded in Oracle Fusion Cloud Applications help supply chain professionals act faster, reduce risk, and improve operational performance MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new AI agents within Oracle Fusion Cloud Applications to help supply chain leaders accelerate decision-making and drive greater efficiency across planning, procurement, manufacturing, maintenance, and logistics. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within supply chain processes to help leaders unlock productivity gains and enhance business performance by automating end-to-end workflows and delivering insig
New recipe and materials management, batch execution, and compliance capabilities in Oracle Fusion Cloud SCM help customers improve control, enhance quality, and lower risk MUMBAI, India, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World -- Oracle today announced new capabilities in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) to help organizations manage the unique requirements of process manufacturing. The latest innovations help organizations that produce goods by mixing or blending ingredients improve real-time production visibility and meet regulatory requirements by connecting formulas, recipes, materials, and batch execution in a unified cloud solution.
New role-based AI agents embedded in Oracle Fusion Cloud Applications transform slow and reactive sales, marketing, and service processes into revenue driving opportunities MUMBAI, Feb. 10, 2026 /PRNewswire/ -- Oracle AI World Tour -- Oracle today announced new role-based AI agents within Oracle Fusion Cloud Applications to help organizations deliver intelligent customer experiences (CX) at scale. Built using Oracle AI Agent Studio for Fusion Applications, the new AI agents are embedded within marketing, sales, and service processes to help CX leaders drive productivity gains and enhance business performance by analyzing unified data, automating processes, and delivering predictive insights
Melius downgraded Oracle from Buy to Hold
DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00
BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously
4 - ORACLE CORP (0001341439) (Issuer)
4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
4 - Avidity Biosciences, Inc. (0001599901) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
SCHEDULE 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)
CERT - ORACLE CORP (0001341439) (Filer)
8-A12B - ORACLE CORP (0001341439) (Filer)
New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr
SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi
Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI
Earnings Results to be released on December 10, 2025, After the Close of the Market AUSTIN, Texas, Dec. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its second quarter fiscal year 2026 results will be released on Wednesday, December 10th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results. The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About Oracle Oracle offers integrated suites of applications plus secure, a
Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis xRNA strategy by adding a scientifically robust, muscle-directed, Antibody Oligonucleotide Conjugates (AOCs™) platform and first-in-disease pipelineExpected to unlock multi-billion-dollar opportunities with planned product launches before 2030 Raises expected 2024-2029 sales CAGR for Novartis from +5% to +6%, and bolsters mid-single digit long-term growthAs part of the agreement, Avidity will separate its early-stage precision cardiology programs into a new company ("SpinCo") prior to closingCo
SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)
SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)
SC 13G - Avidity Biosciences, Inc. (0001599901) (Subject)